Variant report
Variant | nsv975839 |
---|---|
Chromosome Location | chr11:45346121-45350850 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:45335928..45338773-chr11:45344348..45346925,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PRDM11-8 | chr11:45349524-45350967 | ucscGeneNc_uc001myr_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541999104 | chr11:45346128-45346129 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181520270 | chr11:45346134-45346135 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7112192 | chr11:45346161-45346162 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs532190193 | chr11:45346237-45346238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186652515 | chr11:45346238-45346239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547886647 | chr11:45346251-45346252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568892092 | chr11:45346287-45346288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537958508 | chr11:45346307-45346308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554436963 | chr11:45346344-45346345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147598076 | chr11:45346384-45346385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112438152 | chr11:45346403-45346404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553699979 | chr11:45346432-45346433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576806158 | chr11:45346441-45346442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545828388 | chr11:45346452-45346453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565974497 | chr11:45346469-45346470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370315448 | chr11:45346471-45346472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576431431 | chr11:45346510-45346511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376430058 | chr11:45346521-45346522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199499826 | chr11:45346522-45346523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542312372 | chr11:45346578-45346579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548518447 | chr11:45349549-45349550 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs371980624 | chr11:45349560-45349561 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs150809389 | chr11:45349581-45349582 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs189216377 | chr11:45349644-45349645 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs577637359 | chr11:45349663-45349664 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs543154459 | chr11:45349700-45349701 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs568032703 | chr11:45349712-45349713 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs4755315 | chr11:45349726-45349727 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs181934035 | chr11:45349732-45349733 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs542924984 | chr11:45349735-45349736 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs77290946 | chr11:45349789-45349790 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs139192454 | chr11:45349805-45349806 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs114921036 | chr11:45349808-45349809 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs374915602 | chr11:45349822-45349823 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs34592798 | chr11:45349857-45349858 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs78222928 | chr11:45349946-45349947 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs115007375 | chr11:45349989-45349990 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs550836465 | chr11:45350024-45350025 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs4755969 | chr11:45350039-45350040 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs546872256 | chr11:45350059-45350060 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs570523518 | chr11:45350115-45350116 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs114484681 | chr11:45350124-45350125 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs4755970 | chr11:45350127-45350128 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs577572461 | chr11:45350128-45350129 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs76469918 | chr11:45350149-45350150 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs112785364 | chr11:45350158-45350159 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs376893867 | chr11:45350179-45350180 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs34131056 | chr11:45350194-45350195 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs10838450 | chr11:45350207-45350208 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs573766314 | chr11:45350268-45350269 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Parathyroid adenoma | 22454399 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Melanoma | 18172304 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Potocki-Shaffer syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 16608533 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:45342400-45346400 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr11:45344200-45346600 | Enhancers | Fetal Muscle Trunk | muscle |
3 | chr11:45344400-45346400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
4 | chr11:45346000-45346200 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |